SensoDetect AB Logo

SensoDetect AB

Develops AI decision-support solutions for mental illness diagnostics.

SDET | SPGR

Overview

Corporate Details

ISIN(s):
SE0003037456 (+1 more)
LEI:
549300BPUMGJZ3N7QM92
Country:
Sweden
Address:
Arenagatan 31, 215 32 Malmö

Description

SensoDetect AB is a neurodiagnostics MedTech and artificial intelligence (AI) company that develops objective decision-support solutions for mental illness. Based on over 30 years of research in clinical psychoacoustics, the company's core technology analyzes Auditory Brainstem Response (ABR) signals to provide quantitative data on the brain's reaction to sound. This system is designed to assist healthcare professionals in the assessment of psychiatric disorders such as schizophrenia, ADHD, and autism, aiming to improve diagnostic accuracy and patient quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SensoDetect AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SensoDetect AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SensoDetect AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-22 Johan Granath Other Other 1,223,955 183,593.25 SEK
2025-01-21 per-anders hedin Other Other 3,214,285 482,142.75 SEK
2025-01-21 Johan Möllerström Other Other 2,170,535 325,580.25 SEK
2025-01-21 Johan Möllerström Other Other 1,836,610 275,491.50 SEK
2025-01-21 Johan Möllerström Other Other 714,285 107,142.75 SEK
2025-01-21 Wendi Ma Other Other 66,392 9,958.80 SEK
2025-01-21 Per-Anders Hedin Other Other 43,050 6,457.50 SEK
2025-01-21 Wendi Ma Other Other 66,392 N/A

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.